Rituximab (Rituxan)

346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine

Peter Attia MD

An antibody drug that targets CD20, a marker on lymphomas, proving highly effective and changing the landscape of lymphoma treatment.